Ticker brief

ACAD

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
12
authors 14d
7

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-02 · now +0.00 (−1 bearish … +1 bullish)
Who spoke7
authorgradetrader scoresignalsmean sent
@BiopharmIQB·4+0.30
@Quantumup1C-1.953+0.18
@theflynewsC·1+0.50
@doublejtradingC-0.691+0.00
@OzmosiHealthC·1+0.50
@HedgeFundTipsB-0.751+0.10
@Brad_E_SchulzC·1+0.30
Recent signals12of 12 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-07-02@Quantumup1+0.00Citizens reiterated TSHA Market Outperform-$11 after positive meeting readout.·
2026-07-01@BiopharmIQ+0.10Biotech catalyst watchlist with 52 Q3 readouts and named trial dates.·
2026-06-28@BiopharmIQ+0.10Biotech catalyst watchlist with Phase 2/3 readouts in Q3 2026, capped to first six tickers.·
2026-06-26@Brad_E_Schulz+0.30Stocks up at least 4% on elevated volume as of 11:31am.·
2026-06-26@HedgeFundTips+0.10Money-flow list with many tickers; capped first six tickers and mild positive flow implication.·
2026-06-26@BiopharmIQ+0.50ACAD up 12% after CHMP positive opinion with EU decision expected.·
2026-06-26@BiopharmIQ+0.50Biotech open news list with price moves and discrete catalysts, capped to six tickers.·
2026-06-26@OzmosiHealth+0.50DAYBU recommended for EU approval by CHMP.·
2026-06-26@Quantumup1+0.55Mizuho reiterated ACAD Outperform with $35 target after CHMP positive opinion.·
2026-06-26@doublejtrading+0.00Gapper list only with no stance.·
2026-06-26@theflynews+0.50Daybu recommended for approval in EU by CHMP.·
2026-06-22@Quantumup1+0.00BofA reiterates TSHA Buy and raises PO to $10 after REVEAL data.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.